Stratos Genomics Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
60
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$250M
Stratos Genomics General Information
Description
Developer of a genome sequencing technology intended to establish the next gold standard of DNA sequencing. The company's technology uses a simple biochemical reaction to encode the sequence of a DNA molecule into a highly measurable surrogate that encodes the sequence information in high signal-to-noise reporters that enable high-fidelity, single-molecule sequencing in a low-cost nanopore instrument, enabling scientists and clinicians to avail versatile and low-cost DNA sequencing methods.
Contact Information
Website
www.stratosgenomics.comCorporate Office
- World Trade Center East
- 2211 Elliott Avenue, Suite 210
- Seattle, WA 98121
- United States
Corporate Office
- World Trade Center East
- 2211 Elliott Avenue, Suite 210
- Seattle, WA 98121
- United States
Stratos Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 20-May-2020 | $250M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series B3) | 08-Jan-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 16-Jun-2015 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 04-Sep-2013 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 15-Oct-2012 | Completed | Generating Revenue | |||
| 4. Grant | 25-Aug-2011 | Completed | Startup | |||
| 3. Early Stage VC (Series A3) | 08-Jun-2011 | Completed | Startup | |||
| 2. Early Stage VC (Series A2) | 03-Aug-2010 | $3.97M | $4.41M | Completed | Startup | |
| 1. Early Stage VC (Series A1) | $440K | $440K | Completed | Startup |
Stratos Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A5 | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | 1,435,766 | $0.001000 | 8% | $2.66 | $2.66 | 1x | $2.65 | 8.98% |
| Series A1 | 270,672 | $0.001000 | 8% | $1.66 | $1.66 | 1x | $1.66 | 1.69% |
Stratos Genomics Comparisons
Industry
Financing
Details
Stratos Genomics Competitors (25)
One of Stratos Genomics’s 25 competitors is Diagenode, a Formerly VC-backed company based in Seraing, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Diagenode | Formerly VC-backed | Seraing, Belgium | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Egenesis | Venture Capital-Backed | Cambridge, MA | ||||
| GnuBIO | Formerly VC-backed | Cambridge, MA | ||||
| Biocept | Formerly VC-backed | San Diego, CA |
Stratos Genomics Signals
Stratos Genomics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fisk Ventures | Family Office | Minority | ||
| Roche Venture Fund | Corporate Venture Capital | Minority | ||
| Stratos Group | Accelerator/Incubator | Minority |
Stratos Genomics FAQs
-
When was Stratos Genomics founded?
Stratos Genomics was founded in 2007.
-
Where is Stratos Genomics headquartered?
Stratos Genomics is headquartered in Seattle, WA.
-
What is the size of Stratos Genomics?
Stratos Genomics has 60 total employees.
-
What industry is Stratos Genomics in?
Stratos Genomics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Stratos Genomics a private or public company?
Stratos Genomics is a Private company.
-
What is the current valuation of Stratos Genomics?
The current valuation of Stratos Genomics is .
-
What is Stratos Genomics’s current revenue?
The current revenue for Stratos Genomics is .
-
How much funding has Stratos Genomics raised over time?
Stratos Genomics has raised $61.1M.
-
Who are Stratos Genomics’s investors?
Fisk Ventures, Roche Venture Fund, and Stratos Group have invested in Stratos Genomics.
-
Who are Stratos Genomics’s competitors?
Diagenode, Ambry Genetics, Egenesis, GnuBIO, and Biocept are some of the 25 competitors of Stratos Genomics.
-
When was Stratos Genomics acquired?
Stratos Genomics was acquired on 20-May-2020.
-
Who acquired Stratos Genomics?
Stratos Genomics was acquired by Roche.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process